The U.S. Department of Justice announced Wednesday that Connecticut Children’s Medical Center has reached an agreement to cease providing gender‑affirming medical interventions to minors, part of a federal probe that has already produced similar resolutions with other major hospitals.
What the agreement requires
According to the Justice Department, the settlement bars Connecticut Children’s from offering three categories of care to patients under 18: puberty blockers, cross‑sex hormone therapy and gender‑affirming surgical procedures. The hospital has also agreed to pay $500,000 to former patients described by the DOJ as “living with the harmful consequences of ‘gender affirming care.’”
- Puberty suppression agents (puberty blockers) — no longer provided to patients under 18.
- Hormone therapies used to align physical characteristics with a patient's gender identity — restricted for minors.
- Gender‑affirming surgeries for minors — not to be performed.
Federal enforcement and investigative partners
The DOJ said the enforcement action involved multiple components of the federal government, including its Civil Division, the U.S. Attorney’s Office for the Northern District of Texas and the Office of Inspector General at the U.S. Department of Health and Human Services. The announcement framed the resolution as part of broader federal efforts to enforce applicable law in health care settings.
"The Department of Justice will stop at nothing to protect America’s children," Associate Attorney General Stanley Woodward said in a statement.
The department noted Connecticut Children’s is the third major hospital to enter such an agreement, following prior resolutions with Texas Children’s Hospital and the Cleveland Clinic Foundation.
Hospital response and patient privacy
In a statement released Thursday morning, Connecticut Children’s confirmed it reached a resolution and said preserving patient privacy was central to negotiations. The hospital said it complied with federal and state law and that no protected patient information was disclosed to the government during the process.
"We can confirm we have reached a resolution that allows our organization to remain focused on our mission of improving the health and well‑being of children. Most importantly, patient privacy remained our foremost concern throughout this process," the hospital said.
The hospital previously announced last year that it was winding down its gender care program for patients under 19, a decision the institution said then followed consultation with medical and legal experts.
Local implications and broader context
The agreement removes a range of gender‑affirming medical options for Connecticut residents younger than 18 who sought care through Connecticut Children’s. Families who previously pursued treatment at the hospital for puberty suppression, hormone therapy or surgeries will be directly affected by the halt to those services at that facility.
Because the DOJ identified Connecticut Children’s as the third hospital to reach similar terms, the resolution contributes to a pattern of federal intervention that may influence where and how minors can access gender‑related medical care nationwide. The Justice Department framed the action as part of vigorous enforcement of federal law relating to medical providers and pharmaceutical companies.
Quick facts
| Item | Detail |
|---|---|
| Prohibited services for patients under 18 | Puberty blockers, hormone therapy, gender‑affirming surgery |
| Monetary payment | $500,000 to former patients, per DOJ |
| Other hospitals with similar resolutions | Texas Children’s Hospital; Cleveland Clinic Foundation |
What this means for families
Families of minors who had been receiving or considering gender‑affirming medical care at Connecticut Children’s will need to seek alternatives if they wish to continue treatment. The hospital’s prior announcement about winding down its under‑19 program signals that some of these changes were already underway before the federal resolution.
Clinicians, advocates and health systems will likely monitor the settlement closely for its legal and clinical implications. The DOJ's involvement and the civil investigation across agencies underline the complex interplay between federal oversight, medical practice standards and patient privacy protections.
Connecticut Children’s said it has no further comment beyond the DOJ's announcement and its brief statement. Federal and hospital officials did not provide additional procedural details in the initial public disclosures.
This article will be updated with any new information or statements from hospital officials, federal authorities or affected families as it becomes available.
